Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martyn French

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Sexual Health|December 1, 2011
HIV and aging: an overview of an emerging issueSean Slavin, Julian Elliott, Christopher Fairley, et al.
HIV Clinical Trials|May 29, 2002
Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 studyMartyn French, Janaki Amin, Norman Roth, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2011
Robust interferon-α and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ARTDino Bee Aik Tan, Yean Kong Yong, Andrew Lim, et al.
Thorax|May 4, 2010
A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee childrenMichaela Lucas, Pam Nicol, Elizabeth McKinnon, et al.
Diagnostic Microbiology and Infectious Disease|October 4, 2014
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformansYesholata Mahabeer, Christina C Chang, Dianithi Naidu, et al.
The Journal of Infectious Diseases|February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapyMegan Crane, Ben Oliver, Gail Matthews, et al.
Frontiers in Immunology|July 25, 2025
Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatmentAlice A White, Thomas Pearce, Isabelle Coenen, et al.
AIDS Research and Human Retroviruses|January 28, 2012
Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosisPatricia Price, Lewis J Haddow, Jacquita Affandi, et al.
Journal of Virology|March 16, 2006
Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 alleleLachlan Gray, Melissa J Churchill, Niamh Keane, et al.
Clinical Immunology (Orlando, Fla.)|August 11, 2010
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disordersAlex Padiglione, Eman Aleksic, Martyn French, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Sexual Health|December 1, 2011
HIV and aging: an overview of an emerging issueSean Slavin, Julian Elliott, Christopher Fairley, et al.
HIV Clinical Trials|May 29, 2002
Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 studyMartyn French, Janaki Amin, Norman Roth, et al.
Clinical Immunology (Orlando, Fla.)|March 25, 2011
Robust interferon-α and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ARTDino Bee Aik Tan, Yean Kong Yong, Andrew Lim, et al.
Thorax|May 4, 2010
A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee childrenMichaela Lucas, Pam Nicol, Elizabeth McKinnon, et al.
Diagnostic Microbiology and Infectious Disease|October 4, 2014
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformansYesholata Mahabeer, Christina C Chang, Dianithi Naidu, et al.
The Journal of Infectious Diseases|February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapyMegan Crane, Ben Oliver, Gail Matthews, et al.
Frontiers in Immunology|July 25, 2025
Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatmentAlice A White, Thomas Pearce, Isabelle Coenen, et al.
AIDS Research and Human Retroviruses|January 28, 2012
Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosisPatricia Price, Lewis J Haddow, Jacquita Affandi, et al.
Journal of Virology|March 16, 2006
Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 alleleLachlan Gray, Melissa J Churchill, Niamh Keane, et al.
Clinical Immunology (Orlando, Fla.)|August 11, 2010
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disordersAlex Padiglione, Eman Aleksic, Martyn French, et al.
Pageof 3